152 related articles for article (PubMed ID: 3547724)
1. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
Snow GB
Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
[No Abstract] [Full Text] [Related]
2. [Oro- and hypopharyngeal cancer: the Basle concept of therapy].
Wey W; Hünig R; Roth J; Walther E
Sonderb Strahlenther Onkol; 1987; 81():48-55. PubMed ID: 3824132
[No Abstract] [Full Text] [Related]
3. Management to prevent high-sited recurrence of pharyngo-laryngeal cancers.
Remacle M; Robillard T; Deckers C; Mazy G; Hamoir M; Van de Eeckhaut J
Acta Otorhinolaryngol Belg; 1984; 38(5):464-73. PubMed ID: 6535365
[TBL] [Abstract][Full Text] [Related]
4. [Exclusive radiotherapy and radiotherapy-intra-arterial chemotherapy combination in the treatment of advanced cancer of the oropharynx. Retrospective study of 126 cases].
de Carvalho MB; Kowalski LP; Andrade Sobrinko J; Rapoport A; Fava AS; Kanda JL; Góis Filho JF; Chagas JF
Rev Laryngol Otol Rhinol (Bord); 1986; 107(2):119-25. PubMed ID: 3775126
[No Abstract] [Full Text] [Related]
5. Squamous cell carcinoma of the oropharynx and hypopharynx.
Lin DT; Cohen SM; Coppit GL; Burkey BB
Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy of oropharyngeal and hypopharyngeal cancer].
Sonderb Strahlenther Onkol; 1987; 81():1-170. PubMed ID: 3824120
[No Abstract] [Full Text] [Related]
7. [Multidisciplinary treatment of head and neck cancer].
Inuyama Y; Fujii M; Tanaka J; Takaoka T; Hosoda H; Kohno N
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1051-6. PubMed ID: 2414482
[TBL] [Abstract][Full Text] [Related]
8. [Combination therapy of oropharyngeal and hypopharyngeal cancer: present status and outlook].
Sauer R; Schwab W
Sonderb Strahlenther Onkol; 1987; 81():166-70. PubMed ID: 3824127
[No Abstract] [Full Text] [Related]
9. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
10. [A case of hypopharyngeal carcinoma treated with multidisciplinary therapy without loss of the patient's voice].
Tsuruta Y; Sato T; Miyahara H; Yoshino K; Umatani K
Gan No Rinsho; 1985 Oct; 31(13):1717-20. PubMed ID: 3935832
[TBL] [Abstract][Full Text] [Related]
11. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
Rohrmeier M; Langnickel R; Hilpert P
HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
[TBL] [Abstract][Full Text] [Related]
12. [Radio-hyperthermia in oro- and hypopharyngeal cancer].
Herbst M
Sonderb Strahlenther Onkol; 1987; 81():114-21. PubMed ID: 3824123
[No Abstract] [Full Text] [Related]
13. [Multidisciplinary treatment of carcinoma of the oropharynx].
Inuyama Y; Fujii M; Tanaka J; Takaoka T; Hosoda H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1797-803. PubMed ID: 2439017
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the oropharynx.
Gluckman JL; Black RJ; Crissman JD
Otolaryngol Clin North Am; 1985 Aug; 18(3):451-9. PubMed ID: 4047667
[TBL] [Abstract][Full Text] [Related]
15. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
[TBL] [Abstract][Full Text] [Related]
16. [Dynamics and significance of immunoglobulin E (IgE) as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx].
Mayer BA; Enzmann H
Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):316-9. PubMed ID: 3626713
[TBL] [Abstract][Full Text] [Related]
17. Management of squamous cell carcinoma of the pyriform sinus.
Pesavento G; Ferlito A
Acta Otorhinolaryngol Belg; 1984; 38(2):156-63. PubMed ID: 6485766
[No Abstract] [Full Text] [Related]
18. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of oropharyngeal cancer: anatomy and physiology of the oropharynx.
Duvvuri U; Myers JN
Curr Probl Surg; 2009 Feb; 46(2):119-84. PubMed ID: 19111679
[No Abstract] [Full Text] [Related]
20. [Treatment results of concurrent chemoradiotherapy with CDDP or CDGP plus 5-FU for carcinoma of the oropharynx and hypopharynx].
Wadasaki K; Matsuura K; Murakami Y; Kenjo M; Kaneyasu Y; Fujita M; Ito K; Tatsukawa R; Takeno Y; Hirakawa K
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1393-6. PubMed ID: 17876135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]